Concepedia

Craig E. Cole

CE

Statistics

Publications

22

Citations

2.2K

H-Index

18

Active since

2003

Affiliations

Washington University in St. Louis(Current)

Emory University

University of Michigan

The Barbara Ann Karmanos Cancer Institute

Hackensack University Medical Center

Craig E. Cole is an author at Washington University in St. Louis specializing in multiple myeloma, hematologic malignancy therapy, and medicine.

ORCID

Publications per year

2003–2023

22

Publications

22

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

, , +15

Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Peter H. Wiernik, Izidore S. Lossos, Joseph M. Tuscano et al. · Journal of Clinical Oncology · 2008 · 373 citations · Full text

, , +15

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Thomas E. Witzig, Peter H. Wiernik, Timothy D. Moore et al. · Journal of Clinical Oncology · 2009 · 258 citations · Full text

, , +13

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma

Dan T. Vogl, David Dingli, Robert F. Cornell et al. · Journal of Clinical Oncology · 2018 · 162 citations · Full text

, , +16

Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells

Klaus Podar, Yu‐Tzu Tai, Craig E. Cole et al. · Journal of Biological Chemistry · 2003 · 144 citations · Full text

, , +16

1–5 of 22